CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹65.29 | ₹51.05 | ₹34.71 | ₹31.19 | ₹29.82 |
What is the latest Earnings Per Share (EPS) of CIPLA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹65.29 |
| Mar2025 | ₹51.05 |
| Mar2024 | ₹34.71 |
| Mar2023 | ₹31.19 |
| Mar2022 | ₹29.82 |
How is Earnings Per Share (EPS) of CIPLA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹65.29 | 27.89 | |
| Mar2025 | ₹51.05 | 47.08 | |
| Mar2024 | ₹34.71 | 11.29 | |
| Mar2023 | ₹31.19 | 4.59 | |
| Mar2022 | ₹29.82 | - | |
Compare Earnings Per Share (EPS) of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹117,813.6 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹104,535.0 Cr | 1.8% | 6.7% | 8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.3% |
6.1% |
-3.7% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses